Vosoritide potentially life-saving for children with common form of dwarfism

Поделиться
HTML-код
  • Опубликовано: 21 янв 2024
  • Casper has achondroplasia, and has benefited from a new therapy involving the bone growth drug Vosoritide. This trial has been led by Professor Ravi Savarirayan at the Murdoch Children's Research Institute, with the treatment approved from birth in Australia.

Комментарии • 9

  • @valerielaurent4245
    @valerielaurent4245 2 месяца назад +3

    Casser is adorable. Lots of love from Versailles in France ❤

  • @debbiebrannon8874
    @debbiebrannon8874 2 месяца назад +2

    Praying for a healing for him amen

  • @terryharbison172
    @terryharbison172 2 месяца назад +1

    You are the cutest young man i' ve ever seen

  • @valerielaurent4245
    @valerielaurent4245 2 месяца назад +1

    Sorry Casper

  • @EstherFisher-lv6rq
    @EstherFisher-lv6rq 2 месяца назад

    feel sorry for the parents

  • @theresadowns3457
    @theresadowns3457 2 месяца назад

    They must have someone in family with this?

    • @user-co7fo3wx8i
      @user-co7fo3wx8i 2 месяца назад +5

      В 80 % случаев ахондроплазия возникает в результате спонтанной мутации.

    • @theresadowns3457
      @theresadowns3457 2 месяца назад

      @@user-co7fo3wx8i English please